1. |
Du X, Wei C, Hejazi Pastor DP, et al. α1ACT is essential for survival and early cerebellar programming in a critical neonatal window. Neuron, 2019, 102(4): 770-785.
|
2. |
Pan R, Qi X, Wang F, et al. Correlations of calcium voltage-gated channel subunit alpha1 a (cacna1a) gene polymorphisms with benign paroxysmal positional vertigo. Med Sci Monit, 2019, 25(2): 946-951.
|
3. |
Hommersom MP, van Prooije TH, Pennings M, et al. The complexities of CACNA1A in clinical neurogenetics. Journal of Neurology, 2021, 269(6): 3094-3108.
|
4. |
Howell KB, Eggers S, Dalziel K, et al. A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy. Epilepsia, 2018, 59(6): 1177-1187.
|
5. |
Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell, 1996, 87(3): 543-552.
|
6. |
Jouvenceau A, Eunson LH, Spauschus A, et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet, 2001, 358(9284): 801-807.
|
7. |
Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, et al. De novo mutations in epileptic encephalopathies. Nature, 2013, 501: 217-221.
|
8. |
Alehabib E, Esmaeilizadeh Z, Ranji-Burachaloo S, et al. Clinical and molecular spectrum of P/Q type calcium channel Cav2.1 in epileptic patients. Orphanet Journal of Rare Diseases, 2021, 16(1): 461.
|
9. |
Niu X, Yang Y, Chen Y, et al. Genotype-phenotype correlation of CACNA1A variants in children with epilepsy. Developmental Medicine and Child Neurology, 2022, 64(1): 105-111.
|
10. |
Angelini C, van Gils J, Bigourdan A, et al. Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant. European Journal of Medical Genetics, 2018, 62(6): 103530.
|
11. |
Epi4K Consortium. De novo mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies. Am J Hum Genet, 2016, 99(2): 287-298.
|
12. |
Gauquelin L, Hawkins C, Tam EWY, et al. Pearls & Oy-sters: fatal brain edema is a rare complication of severe CACNA1A-related disorder. Neurology, 2020, 94(14): 631-634.
|
13. |
Indelicato E, Nachbauer W, Karner E, et al. The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature. European Journal of Neurology, 2019, 26(1): e66-e67.
|
14. |
Rajakulendran S, Graves TD, Labrum RW, et al. Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy. The Journal of Physiology, 2009, 588: 1905-1913.
|
15. |
Pietrobon D. Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine. J Physiol, 2010, 588(11): 1871-1878.
|
16. |
Jiang X, Raju PK, D'Avanzo N, et al. Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome. Epilepsia, 2019, 60(9): 1881-1894.
|
17. |
Cianfoni A, Caulo M, Cerase A, et al. Seizure-induced brain lesions: a wide spectrum of variably reversible MRI abnormalities. Eur J Radiol, 2013, 82(11): 1964-1972.
|
18. |
Tian X, Ye J, Zeng Q, et al. The clinical outcome and neuroimaging of acute encephalopathy after status epilepticus in Dravet syndrome. Dev Med Child Neurol, 2018, 60(6): 566-573.
|
19. |
Hamdan FF, Myers CT, Cossette P, et al. High rate of recurrent de novo mutations in developmental and epileptic encephalopathies. Am J Hum Genet, 2017, 101(5): 664-685.
|
20. |
Travaglini L, Nardella M, Bellacchio E, et al. Missense mutations of CACNA1A are a frequent cause of autosomal dominant nonprogressive congenital ataxia. Eur J Paediatr. Neurol, 2017, 21(3): 450-456.
|
21. |
Balck A, Tunc S, Schmitz J, et al. A novel frameshift CACNA1A mutation causing episodic ataxia type 2. Cerebellum, 2018, 17(4): 504-506.
|
22. |
Reinson K, Õiglane-Shlik E, Talvik I, et al. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy. American Journal of Medical Genetics, 2016, 170(8): 2173-2176.
|
23. |
Gudenkauf FJ, Azamian MS, Hunter JV, et al. A novel CACNA1A variant in a child with early stroke and intractable epilepsy. Mol Genet Genomic Med, 2020, 8(10): e1383.
|
24. |
Le Roux M, Barth M, Gueden S, et al. CACNA1A-associated epilepsy: electroclinical findings and treatment response on seizures in 18 patients. European Journal of Paediatric Neurology, 2021, 33: 75-85.
|